DXN HOLDINGS BHD. (5318) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DXN HOLDINGS BHD. (5318) has a cash flow conversion efficiency ratio of 0.066x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM94.49 Million ≈ $23.72 Million USD) by net assets (RM1.44 Billion ≈ $360.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View 5318 stock price and chart for real-time trading data and today's change.
DXN HOLDINGS BHD. - Cash Flow Conversion Efficiency Trend (2020–2026)
This chart illustrates how DXN HOLDINGS BHD.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see market cap of DXN HOLDINGS BHD. for the company's overall valuation and market capitalisation.
DXN HOLDINGS BHD. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DXN HOLDINGS BHD. ranked by their cash flow conversion efficiency. Also see 5318 asset base for a full breakdown of the balance sheet.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vibhavadi Medical Center Public Company Limited
BK:VIBHA
|
0.043x |
|
Yunnan Yunwei Co Ltd Class A
SHG:600725
|
-0.044x |
|
Mastek Limited
NSE:MASTEK
|
0.047x |
|
Global PMX Co Ltd
TW:4551
|
0.038x |
|
Hubei Kailong Chemical Group Co Ltd
SHE:002783
|
0.000x |
|
Lionco Pharm Grp Co Ltd
SHG:603669
|
-0.127x |
|
Hainan Shuangcheng Pharmaceut
SHE:002693
|
0.080x |
|
Client Service International Inc
SHE:300663
|
0.039x |
Annual Cash Flow Conversion Efficiency for DXN HOLDINGS BHD. (2020–2026)
The table below shows the annual cash flow conversion efficiency of DXN HOLDINGS BHD. from 2020 to 2026. Review 5318 free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-02-28 | RM1.44 Billion ≈ $360.58 Million |
RM334.70 Million ≈ $84.03 Million |
0.233x | -29.31% |
| 2025-02-28 | RM1.35 Billion ≈ $338.88 Million |
RM444.99 Million ≈ $111.72 Million |
0.330x | +24.18% |
| 2024-02-29 | RM1.36 Billion ≈ $341.01 Million |
RM360.60 Million ≈ $90.54 Million |
0.265x | +10.16% |
| 2023-02-28 | RM1.03 Billion ≈ $257.38 Million |
RM247.06 Million ≈ $62.03 Million |
0.241x | -24.77% |
| 2022-02-28 | RM811.62 Million ≈ $203.77 Million |
RM260.01 Million ≈ $65.28 Million |
0.320x | -19.44% |
| 2021-02-28 | RM629.69 Million ≈ $158.09 Million |
RM250.41 Million ≈ $62.87 Million |
0.398x | -8.06% |
| 2020-02-29 | RM710.69 Million ≈ $178.43 Million |
RM307.39 Million ≈ $77.18 Million |
0.433x | -- |
About DXN HOLDINGS BHD.
DXN Holdings Bhd. manufactures and sales health supplements and other products on direct sales basis in Latin America, Malaysia, Asia, North America, Africa, Europe, the Middle East, and Oceania. It offers coffee, tea, nutritious drinks, juices, confectionery and biscuits, herbs, mushrooms and fungi, premixes, toothpastes, face masks, perfumes, body foams, shampoos, soaps, powders, travel kits, t… Read more